Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8822511 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

Patent 8822511 was granted and assigned to Incyte on September, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Incyte

Current Assignee

Incyte

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

88225110

Patent Inventor Names

Eddy W. Yue0

Andrew P. Combs0

Richard B. Sparks0

Wenyu Zhu0

Date of Patent

September 2, 2014

Patent Application Number

140331170

Date Filed

September 20, 2013

Patent Citations Received

‌

US Patent 12071391 Methods for making and using endoxifen

‌

US Patent 11680036 Methods for making and using endoxifen

Patent Primary Examiner

‌

Joseph Kosack

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8822511 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API